Order Article Reprints

Iles J, Zmuidinaite R, Sadee C, Gardiner A, Lacey J, Harding S, Ule J, Roblett D, Heeney J, Baxendale H, et al. SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin—Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases. International Journal of Molecular Sciences. 2022; 23(8):4126. https://doi.org/10.3390/ijms23084126

Iles, Jason, Raminta Zmuidinaite, Christoph Sadee, Anna Gardiner, Jonathan Lacey, Stephen Harding, Jernej Ule, Debra Roblett, Jonathan Heeney, Helen Baxendale, and et al. 2022. "SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin—Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases" International Journal of Molecular Sciences 23, no. 8: 4126. https://doi.org/10.3390/ijms23084126

Iles, J., Zmuidinaite, R., Sadee, C., Gardiner, A., Lacey, J., Harding, S., Ule, J., Roblett, D., Heeney, J., Baxendale, H., & Iles, R. K. (2022). SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin—Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases. International Journal of Molecular Sciences, 23(8), 4126. https://doi.org/10.3390/ijms23084126